Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, Aldeyra, Cantargia, Celldex, Ferring, OSE, Redx, Tharimmune, Thetis, Tiziana, Topas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Helio Genomics, Heartflow, Ibex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptose, Chemomab, Eupraxia, Immutep, Janus, J&J, Nanobiotix, Opus, PTC, Recursion, Regeneration, Spyre, Theralase, Unity.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alterity, Chemomab, Yoltech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Elekta, Endospan, Merit Medical, Natera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AN2, Astrazeneca, Transcode.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Impedimed.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Design, Tris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avenda Health, Castle Biosciences, Paragonix, Spectral AI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Immunic, Napo, Therini, Xencor.